Neuberger High Yield Strategies Fund Inc. Common Stock (NHS)
EBITDA Growth
15.70%
TTM · Period ending:
NHS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported15.70%period ending
Latest reported15.70%period ending
NHS TTM EBITDA YoY % (8.53% → 15.70%)
Year-over-year change
High-resolution chart · PNG
NHS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 15.6997% | |
| 14.0935% | |
| 96.1165% | |
| 493.0207% | |
| 212.321% | |
| -1,042.2066% | |
| -184.0184% | |
| -101.8867% | |
| -64.3284% | |
| 16.1112% | |
| 59.0677% | |
| 147.9022% | |
| 138.4788% | |
| 14.5885% | |
| -34.0207% | |
| -65.429% | |
| -48.1242% | |
| -4.0293% | |
| -4.9645% | |
| -6.5657% | |
| -5.313% | |
| 28.958% | |
| 96.1614% | |
| 74.1249% | |
| 43.027% | |
| -60.3894% | |
| -81.5899% | |
| 34.0159% | |
| 151.1262% | |
| 37.9894% | |
| -25.1361% | |
| -0.4338% | |
| 11.2918% | |
| 8.5331% |